Read the latest positive news, breakthroughs, and inspiring stories about biotech innovation, curated daily by BrightWire.
When big pharma abandoned rare disease treatments, Pennsylvania's Amish and Mennonite communities decided to build their own gene therapy company. Now they're developing life-saving medicines that biotech giants left behind. ---
Two food tech companies just cracked a major code in making lab-grown meat affordable and practical. Their breakthrough achieves 19 times more protein than previous methods, potentially bringing sustainable meat to your local grocery store.
A new public-private partnership modeled after the COVID-19 vaccine effort aims to fast-track personalized cancer vaccines that target tumors in patients who already have the disease. The initiative launches in December and could transform cancer treatment using breakthrough mRNA technology.
A new biotech company is launching trials for a psychedelic-like drug that could ease Parkinson's symptoms without the hallucinogenic effects. The breakthrough approach offers fresh hope for millions living with the movement disorder. ---
A leukemia treatment accidentally revealed a promising new path to controlling blood sugar. Now scientists are turning that surprise discovery into a fully funded diabetes drug company.
A biotech company just achieved what industry giants couldn't for 15 years: making a promising cancer immunotherapy targeting OX40 actually work. The breakthrough offers new hope for patients with certain head and neck cancers.
A federal health agency is backing biotech companies developing personalized RNA treatments that could revolutionize how we treat diseases. The funding marks a major step toward making customized medicine accessible to everyday patients.
Researchers just proved that ultrathin diamond can produce electricity when bent, overturning a century of scientific belief. The breakthrough could power medical implants and tiny sensors without batteries.
A biotech startup's experimental pill designed to replicate exercise benefits and curb appetite has passed its first human safety trial with flying colors. The drug could offer a new approach to weight management without the harsh side effects that make many people quit current medications.
A Bengaluru biotech company is converting agricultural waste into biodegradable alternatives to the petroleum-based plastics hiding in your shampoo and toothpaste. Their breakthrough could help India shift from importing specialty ingredients to exporting them worldwide.
A Gurugram company is developing cancer treatments that can be made in advance and stored, potentially making cutting-edge cell therapy available to more patients at lower costs. East Ocyon Bio just raised $4.2 million to move toward human trials of its made-in-India approach.
A Bengaluru biotech company just raised $3 million to bring faster infection tests to hospitals, cutting diagnosis time from days to hours. Their CRISPR-based technology could help stop the spread of drug-resistant infections across India and beyond.